When comparing these groups, intracellular SMN expression levels in the R2, R3, and R4 populations from the SMA subjects were found to be significantly reduced compared with those from the control subjects (Fig 3A: p < 0.001). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.